IgA Nephropathy (IgAN) is a slow-progressing autoimmune kidney disorder that poses long-term risks for renal failure. With increased disease awareness and the emergence of targeted therapies, the IgA Nephropathy Market is poised for sustained growth in the coming years.
Global Epidemiological Landscape
IgAN affects an estimated 2.5 people per 100,000 annually. While it is the most...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek